[HTML][HTML] Expansion of human SCID-repopulating cells under hypoxic conditions

GH Danet, Y Pan, JL Luongo… - The Journal of …, 2003 - Am Soc Clin Investig
GH Danet, Y Pan, JL Luongo, DA Bonnet, MC Simon
The Journal of clinical investigation, 2003Am Soc Clin Investig
It has been proposed that bone marrow (BM) hematopoietic stem and progenitor cells are
distributed along an oxygen (O 2) gradient, where stem cells reside in the most hypoxic
areas and proliferating progenitors are found in O 2-rich areas. However, the effects of
hypoxia on human hematopoietic stem cells (HSCs) have not been characterized. Our
objective was to evaluate the functional and molecular responses of human BM progenitors
and stem cells to hypoxic conditions. BM lineage–negative (Lin–) CD34+ CD38–cells were …
It has been proposed that bone marrow (BM) hematopoietic stem and progenitor cells are distributed along an oxygen (O 2) gradient, where stem cells reside in the most hypoxic areas and proliferating progenitors are found in O 2-rich areas. However, the effects of hypoxia on human hematopoietic stem cells (HSCs) have not been characterized. Our objective was to evaluate the functional and molecular responses of human BM progenitors and stem cells to hypoxic conditions. BM lineage–negative (Lin–) CD34+ CD38–cells were cultured in serum-free medium under 1.5% O 2 (hypoxia) or 20% O 2 (normoxia) for 4 days. Using limiting dilution analysis, we demonstrate that the absolute number of SCID-repopulating cells (SRCs) increased by 5.8-fold in hypoxic cultures compared with normoxia, and by 4.2-fold compared with freshly isolated Lin–CD34+ CD38–cells. The observed increase in BM-repopulating activity was associated with a preferential expansion of Lin–CD34+ CD38–cells. We also demonstrate that, in response to hypoxia, hypoxia-inducible factor-1α protein was stabilized, surface expression of angiogenic receptors was upregulated, and VEGF secretion increased in BM Lin–CD34+ cultures. The use of low O 2 levels to enhance the survival and/or self-renewal of human BM HSCs in vitro represents an important advance and could have valuable clinical implications.
The Journal of Clinical Investigation